logo
  

Kering Appoints Sarah Crook As CEO Of Christopher Kane

French luxury and retail group Kering (PPRUY, PPRUF), previously known as PPR, said that it has appointed Sarah Crook as Chief Executive Officer of the brand Christopher Kane, effective 17 November 2014. She will report to Marco Bizzarri, CEO of Kering 'Luxury - Couture & Leather Goods' division.

Sarah Crook will succeed Alexandre de Brettes who has successfully completed the integration of Christopher Kane Ltd within the Kering Group. He will remain within the Christopher Kane company to ensure a smooth transition, before taking another position within the Group.

Previously strategic brand & business consultant to the British Fashion Council and leading fashion brands for two years, Sarah Crook served at Stella McCartney between 2004 and 2012, first as merchandise & business development director and then as vice-president.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
AbbVie (ABBV) Monday announced a collaboration and option-to-license agreement with Gilgamesh Pharmaceuticals, a clinical stage neuroscience biotech firm, to develop next-generation treatment approaches and unmet needs in psychiatric disorders. AbbVie noted that the first-generation compounds may... Healthwest Minerals, Inc. d/b/a Mt. Capra Products has recalled 1,506 boxes of Goat Milk Formula Recipe Kit, also urging consumers to immediately discontinue use of the product as infant formula. The firm does not recommend using this product for infants from 0-12 months of age. Major companies, including Amazon.com Inc., Microsoft Corp., Morgan Stanley, Pfizer and others, have announced around 15 billion euros or $16.2 billion worth foreign investments in France as part of the country's annual 'Choose France' business summit, reports said. French President Emmanuel Macron kicks off the summit of 180 CEOs and executives on Monday, aiming to showcase foreign investment.

This week, we bring a mix of medical breakthroughs and setbacks. Lyko's MDMA therapy could become the first FDA-approved psychedelic treatment if all goes well as planned. A tragic loss occurred in Pfizer's Duchenne trial and a new study has raised concerns about ultra-processed foods. Find out why Long Beach declared a public health emergency and how Novavax's actions signal optimism.

View More Videos
RELATED NEWS
Follow RTT